Immunization, HepB3 in Central Europe and the Baltics
Central Europe and the Baltics: Immunization, HepB3 was 78.1% in 2024. ◆ Volatile
Immunization, HepB3 in Central Europe and the Baltics, 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
The most recent figure for immunization, hepb3 in Central Europe and the Baltics is 78.1%, measured in 2024.
That represents a change of down 1.9% on the previous year and down 8.5% over ten years.
Over the whole period, immunization, hepb3 in Central Europe and the Baltics peaked at 87.1% in 2010 and was at its lowest, 0.0%, in 1985.
Central Europe and the Baltics ranks 35th of 47 groups on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in Central Europe and the Baltics, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.0% | — |
| 1990 | 0.0% | — |
| 1991 | 0.5% | — |
| 1992 | 5.9% | +1093.2% |
| 1993 | 6.6% | +10.4% |
| 1994 | 7.6% | +15.5% |
| 1995 | 14.8% | +95.5% |
| 1996 | 47.2% | +219.1% |
| 1997 | 61.9% | +31.1% |
| 1998 | 66.7% | +7.7% |
| 1999 | 68.9% | +3.3% |
| 2000 | 73.9% | +7.3% |
| 2001 | 72.1% | -2.4% |
| 2002 | 80.1% | +11.1% |
| 2003 | 80.5% | +0.5% |
| 2004 | 82.7% | +2.7% |
| 2005 | 82.9% | +0.3% |
| 2006 | 82.9% | -0.1% |
| 2007 | 86.6% | +4.5% |
| 2008 | 86.6% | -0.0% |
| 2009 | 86.4% | -0.3% |
| 2010 | 87.1% | +0.9% |
| 2011 | 87.1% | -0.0% |
| 2012 | 86.6% | -0.6% |
| 2013 | 85.9% | -0.7% |
| 2014 | 85.3% | -0.7% |
| 2015 | 83.9% | -1.6% |
| 2016 | 83.4% | -0.7% |
| 2017 | 82.8% | -0.7% |
| 2018 | 82.0% | -0.9% |
| 2019 | 82.2% | +0.1% |
| 2020 | 80.8% | -1.6% |
| 2021 | 81.1% | +0.3% |
| 2022 | 81.2% | +0.1% |
| 2023 | 79.6% | -2.1% |
| 2024 | 78.1% | -1.9% |
Biggest year-on-year movements
Years where Immunization, HepB3 in Central Europe and the Baltics changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 1992 | +1093.2% | 0.5% | 5.9% |
| 1996 | +219.1% | 14.8% | 47.2% |
| 1995 | +95.5% | 7.6% | 14.8% |
| 1997 | +31.1% | 47.2% | 61.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.0% | 0.0% | 0.0% | 5 |
| 1990s | 28.0% | 0.0% | 68.9% | 10 |
| 2000s | 81.5% | 72.1% | 86.6% | 10 |
| 2010s | 84.6% | 82.0% | 87.1% | 10 |
| 2020s | 80.2% | 78.1% | 81.2% | 5 |
More health data for Central Europe and the Baltics
- Population ages 30-34, male, annual growth rate -4.09 % change on previous year (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate -1.57 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0352 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -1.55 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.0319 units per person (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 25-29, male, annual growth rate -3.51 % change on previous year (2025)
- Population ages 25-29, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hepb3 in Central Europe and the Baltics?
- Immunization, hepb3 in Central Europe and the Baltics was 78.1% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Central Europe and the Baltics?
- The highest recorded value was 87.1% in 2010.
- What is the lowest immunization, hepb3 recorded in Central Europe and the Baltics?
- The lowest recorded value was 0.0% in 1985.
- How does Central Europe and the Baltics rank for immunization, hepb3?
- Central Europe and the Baltics ranks 35th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in Central Europe and the Baltics?
- Over the last ten years it is down 8.5%. The long-run trend across the full record is volatile.
- Where does this Central Europe and the Baltics data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.